Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study
- S. Park
- , J. M. Sun
- , Y. L. Choi
- , D. Oh
- , H. K. Kim
- , T. Lee
- , S. A. Chi
- , S. H. Lee
- , Y. S. Choi
- , S. H. Jung
- , M. J. Ahn
- , Y. C. Ahn
- , K. Park
- , Y. M. Shim
- Sungkyunkwan University
- Duke University
Research output: Contribution to journal › Article › peer-review
53
Link opens in a new tab
Scopus
citations